• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Vision Care Institute reaches attendee milestone

Article

The Vision Care Institute, an affiliate of Johnson & Johnson Vision Care Inc., has announced that 100,000 eye care professionals attended courses throughout its network of 14 sites worldwide.

 

Jacksonville, FL-The Vision Care Institute, an affiliate of Johnson & Johnson Vision Care Inc., has announced that 100,000 eye care professionals attended courses throughout its network of 14 sites worldwide.

Launched in 2004, the Vision Care Institute has evolved from one institute in the United States to sites across four continents. To date, there have been more than 4,000 courses taught by 256 faculty members in 30 languages to accommodate attendees from 56 countries.

“Having 100,000 eye care professionals come through our doors is an incredible milestone that shows the importance placed on continuous learning,” said Ian Davies, head of global professional education for Johnson & Johnson Vision Care. “We have challenged ourselves to understand the diverse issues and concerns of practicing eye care professionals in both developing and developed markets so we can foster more confident and current vision care that will ultimately benefit patients.”

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Related Videos
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.